AH Equity Partners Bio IV, L.L.C. insider trades: Braveheart Bio (BRVE) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where AH Equity Partners Bio IV, L.L.C. reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE | ↑ Buy | 1,100,000 | $18.00 | $19.8M | By AH Bio Fund IV, L.P. | Aug 11, 2026 (4d) |
| Oct 15, 2024 | CAMP | ↑ Buy | 545,454 | $11.00 | $6.0M | By AH Bio Fund IV, L.P., as nominee | Oct 17, 2024 (2d) |
| Oct 15, 2024 | CAMP | ↑ Buy | 181,818 | $11.00 | $2.0M | By AH Bio Fund I, L.P., as nominee | Oct 17, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BRVE insiders
Open-market trades in the last 12 months
About AH Equity Partners Bio IV, L.L.C.'s insider trades
AH Equity Partners Bio IV, L.L.C. is a 10% owner of Braveheart Bio (BRVE). Since Oct 15, 2024, it has reported 3 open-market purchases worth $27.8M and no sales on SEC Form 4. In the last 12 months: 1 buy ($19.8M).
Its filings also include conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BRVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.